Pharmaceutical preparations company · DE · FY ends Dec · Revenue $2M · -202.65% margin · -$431K FCF
The business is unprofitable at the operating level (-245.77% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 66.1% YoY with margins expanding 197.0pp.
Negative free cash flow of -$795K. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$2M
▲ +66.1% YoY
Net Income (TTM)
-$11M
▼ -12.4% YoY
Op. Margin
-202.65%
▲ +197.0pp YoY
ROIC
-59.85%
▲ +13.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$431K
▲ +53.2% YoY
Op. Cash Flow (TTM)
-$431K
▲ +53.5% YoY
Net Debt
$6M
Cash & Equiv.
$633.00
Continue Research